1-214640439-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_016343.4(CENPF):​c.2101A>G​(p.Met701Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0629 in 1,614,010 control chromosomes in the GnomAD database, including 4,158 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M701L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.072 ( 462 hom., cov: 33)
Exomes 𝑓: 0.062 ( 3696 hom. )

Consequence

CENPF
NM_016343.4 missense

Scores

17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.70

Publications

22 publications found
Variant links:
Genes affected
CENPF (HGNC:1857): (centromere protein F) This gene encodes a protein that associates with the centromere-kinetochore complex. The protein is a component of the nuclear matrix during the G2 phase of interphase. In late G2 the protein associates with the kinetochore and maintains this association through early anaphase. It localizes to the spindle midzone and the intracellular bridge in late anaphase and telophase, respectively, and is thought to be subsequently degraded. The localization of this protein suggests that it may play a role in chromosome segregation during mitotis. It is thought to form either a homodimer or heterodimer. Autoantibodies against this protein have been found in patients with cancer or graft versus host disease. [provided by RefSeq, Jul 2008]
CENPF Gene-Disease associations (from GenCC):
  • Stromme syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Illumina, Genomics England PanelApp, Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017424524).
BP6
Variant 1-214640439-A-G is Benign according to our data. Variant chr1-214640439-A-G is described in ClinVar as [Benign]. Clinvar id is 1209810.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.131 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CENPFNM_016343.4 linkc.2101A>G p.Met701Val missense_variant Exon 12 of 20 ENST00000366955.8 NP_057427.3 P49454
CENPFXM_017000086.3 linkc.2101A>G p.Met701Val missense_variant Exon 12 of 20 XP_016855575.1 P49454
CENPFXM_011509082.4 linkc.2101A>G p.Met701Val missense_variant Exon 12 of 19 XP_011507384.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CENPFENST00000366955.8 linkc.2101A>G p.Met701Val missense_variant Exon 12 of 20 1 NM_016343.4 ENSP00000355922.3 P49454
CENPFENST00000706765.1 linkc.2101A>G p.Met701Val missense_variant Exon 12 of 19 ENSP00000516538.1 A0A9L9PXU7

Frequencies

GnomAD3 genomes
AF:
0.0714
AC:
10861
AN:
152186
Hom.:
460
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0951
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.106
Gnomad ASJ
AF:
0.0522
Gnomad EAS
AF:
0.118
Gnomad SAS
AF:
0.140
Gnomad FIN
AF:
0.0218
Gnomad MID
AF:
0.0506
Gnomad NFE
AF:
0.0500
Gnomad OTH
AF:
0.0688
GnomAD2 exomes
AF:
0.0831
AC:
20806
AN:
250402
AF XY:
0.0817
show subpopulations
Gnomad AFR exome
AF:
0.0981
Gnomad AMR exome
AF:
0.153
Gnomad ASJ exome
AF:
0.0541
Gnomad EAS exome
AF:
0.134
Gnomad FIN exome
AF:
0.0252
Gnomad NFE exome
AF:
0.0488
Gnomad OTH exome
AF:
0.0650
GnomAD4 exome
AF:
0.0621
AC:
90704
AN:
1461706
Hom.:
3696
Cov.:
34
AF XY:
0.0638
AC XY:
46411
AN XY:
727132
show subpopulations
African (AFR)
AF:
0.0976
AC:
3268
AN:
33476
American (AMR)
AF:
0.148
AC:
6605
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.0517
AC:
1351
AN:
26130
East Asian (EAS)
AF:
0.124
AC:
4911
AN:
39684
South Asian (SAS)
AF:
0.145
AC:
12539
AN:
86234
European-Finnish (FIN)
AF:
0.0267
AC:
1428
AN:
53384
Middle Eastern (MID)
AF:
0.0711
AC:
410
AN:
5766
European-Non Finnish (NFE)
AF:
0.0505
AC:
56193
AN:
1111946
Other (OTH)
AF:
0.0662
AC:
3999
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4928
9856
14783
19711
24639
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2314
4628
6942
9256
11570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0715
AC:
10894
AN:
152304
Hom.:
462
Cov.:
33
AF XY:
0.0724
AC XY:
5394
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.0954
AC:
3963
AN:
41552
American (AMR)
AF:
0.107
AC:
1633
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.0522
AC:
181
AN:
3470
East Asian (EAS)
AF:
0.118
AC:
611
AN:
5164
South Asian (SAS)
AF:
0.140
AC:
674
AN:
4822
European-Finnish (FIN)
AF:
0.0218
AC:
232
AN:
10626
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0500
AC:
3399
AN:
68038
Other (OTH)
AF:
0.0699
AC:
148
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
519
1038
1556
2075
2594
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
130
260
390
520
650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0611
Hom.:
950
Bravo
AF:
0.0803
TwinsUK
AF:
0.0574
AC:
213
ALSPAC
AF:
0.0501
AC:
193
ESP6500AA
AF:
0.0903
AC:
398
ESP6500EA
AF:
0.0542
AC:
466
ExAC
AF:
0.0819
AC:
9949
EpiCase
AF:
0.0505
EpiControl
AF:
0.0519

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 07, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Stromme syndrome Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.83
T
BayesDel_noAF
Benign
-0.83
CADD
Benign
3.2
DANN
Benign
0.38
DEOGEN2
Benign
0.013
T
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.0080
N
LIST_S2
Benign
0.054
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-0.90
T
PhyloP100
1.7
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.29
N
REVEL
Benign
0.074
Sift
Benign
0.30
T
Sift4G
Benign
0.30
T
Polyphen
0.019
B
Vest4
0.0070
MPC
0.053
ClinPred
0.0030
T
GERP RS
0.27
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.032
gMVP
0.064
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3795524; hg19: chr1-214813782; COSMIC: COSV65277629; API